ImmuPharma (LON:IMM) Trading 15.6% Higher – What’s Next?

Shares of ImmuPharma plc (LON:IMMGet Free Report) shot up 15.6% on Friday . The company traded as high as GBX 4.50 ($0.06) and last traded at GBX 4.16 ($0.05). 9,739,506 shares were traded during trading, a decline of 47% from the average session volume of 18,399,727 shares. The stock had previously closed at GBX 3.60 ($0.04).

ImmuPharma Stock Performance

The stock has a market capitalization of £17.24 million, a PE ratio of -414.00 and a beta of 1.53. The stock has a 50-day moving average price of GBX 1.71 and a two-hundred day moving average price of GBX 1.72.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

Featured Stories

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.